annual CFF:
$2.45B+$1.81B(+282.69%)Summary
- As of today (July 3, 2025), PCVX annual cash flow from financing activities is $2.45 billion, with the most recent change of +$1.81 billion (+282.69%) on December 31, 2024.
- During the last 3 years, PCVX annual CFF has risen by +$2.43 billion (+13658.75%).
- PCVX annual CFF is now at all-time high.
Performance
PCVX Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$759.00K-$4.15M(-84.53%)Summary
- As of today (July 3, 2025), PCVX quarterly cash flow from financing activities is $759.00 thousand, with the most recent change of -$4.15 million (-84.53%) on March 31, 2025.
- Over the past year, PCVX quarterly CFF has dropped by -$817.44 million (-99.91%).
- PCVX quarterly CFF is now -99.95% below its all-time high of $1.52 billion, reached on September 30, 2024.
Performance
PCVX quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$1.63B-$817.44M(-33.39%)Summary
- As of today (July 3, 2025), PCVX TTM cash flow from financing activities is $1.63 billion, with the most recent change of -$817.44 million (-33.39%) on March 31, 2025.
- Over the past year, PCVX TTM CFF has increased by +$214.62 million (+15.15%).
- PCVX TTM CFF is now -33.39% below its all-time high of $2.45 billion, reached on December 31, 2024.
Performance
PCVX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PCVX Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +282.7% | -99.9% | +15.2% |
| 3 y3 years | +10000.0% | -99.3% | +1171.0% |
| 5 y5 years | +5790.5% | -99.3% | +292.1% |
PCVX Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -100.0% | at low | -33.4% | +820.2% |
| 5 y | 5-year | at high | >+9999.0% | -100.0% | +2008.3% | -33.4% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -100.0% | +1085.7% | -33.4% | >+9999.0% |
PCVX Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $759.00K(-84.5%) | $1.63B(-33.4%) |
| Dec 2024 | $2.45B(+282.7%) | $4.91M(-99.7%) | $2.45B(+0.1%) |
| Sep 2024 | - | $1.52B(+1272.7%) | $2.45B(+149.7%) |
| Jun 2024 | - | $110.37M(-86.5%) | $979.85M(-30.8%) |
| Mar 2024 | - | $818.20M(>+9900.0%) | $1.42B(+121.4%) |
| Dec 2023 | $639.81M(-25.7%) | $2.73M(-94.4%) | $639.81M(-50.5%) |
| Sep 2023 | - | $48.55M(-91.1%) | $1.29B(+0.4%) |
| Jun 2023 | - | $546.97M(+1216.0%) | $1.29B(+62.8%) |
| Mar 2023 | - | $41.56M(-93.7%) | $792.09M(-8.1%) |
| Dec 2022 | $861.55M(+4741.2%) | $656.63M(+1391.8%) | $861.55M(+303.2%) |
| Sep 2022 | - | $44.02M(-11.8%) | $213.67M(+20.5%) |
| Jun 2022 | - | $49.88M(-55.1%) | $177.25M(+38.1%) |
| Mar 2022 | - | $111.02M(+1168.2%) | $128.33M(+621.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $17.80M(-95.3%) | $8.75M(+15.2%) | $17.80M(+85.4%) |
| Sep 2021 | - | $7.60M(+694.9%) | $9.60M(+371.8%) |
| Jun 2021 | - | $956.00K(+96.3%) | $2.03M(-99.2%) |
| Mar 2021 | - | $487.00K(-12.3%) | $265.56M(-29.2%) |
| Dec 2020 | $374.87M(+801.8%) | $555.00K(+1441.7%) | $374.87M(-9.8%) |
| Sep 2020 | - | $36.00K(-100.0%) | $415.67M(-0.1%) |
| Jun 2020 | - | $264.48M(+140.9%) | $416.00M(+174.7%) |
| Mar 2020 | - | $109.80M(+165.5%) | $151.44M(+264.3%) |
| Dec 2019 | $41.57M(-33.2%) | $41.35M(>+9900.0%) | $41.57M(>+9900.0%) |
| Sep 2019 | - | $368.00K(-577.9%) | $215.00K(-240.5%) |
| Jun 2019 | - | -$77.00K(+1.3%) | -$153.00K(+101.3%) |
| Mar 2019 | - | -$76.00K | -$76.00K |
| Dec 2018 | $62.19M | - | - |
FAQ
- What is Vaxcyte annual cash flow from financing activities?
- What is the all time high annual CFF for Vaxcyte?
- What is Vaxcyte annual CFF year-on-year change?
- What is Vaxcyte quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Vaxcyte?
- What is Vaxcyte quarterly CFF year-on-year change?
- What is Vaxcyte TTM cash flow from financing activities?
- What is the all time high TTM CFF for Vaxcyte?
- What is Vaxcyte TTM CFF year-on-year change?
What is Vaxcyte annual cash flow from financing activities?
The current annual CFF of PCVX is $2.45B
What is the all time high annual CFF for Vaxcyte?
Vaxcyte all-time high annual cash flow from financing activities is $2.45B
What is Vaxcyte annual CFF year-on-year change?
Over the past year, PCVX annual cash flow from financing activities has changed by +$1.81B (+282.69%)
What is Vaxcyte quarterly cash flow from financing activities?
The current quarterly CFF of PCVX is $759.00K
What is the all time high quarterly CFF for Vaxcyte?
Vaxcyte all-time high quarterly cash flow from financing activities is $1.52B
What is Vaxcyte quarterly CFF year-on-year change?
Over the past year, PCVX quarterly cash flow from financing activities has changed by -$817.44M (-99.91%)
What is Vaxcyte TTM cash flow from financing activities?
The current TTM CFF of PCVX is $1.63B
What is the all time high TTM CFF for Vaxcyte?
Vaxcyte all-time high TTM cash flow from financing activities is $2.45B
What is Vaxcyte TTM CFF year-on-year change?
Over the past year, PCVX TTM cash flow from financing activities has changed by +$214.62M (+15.15%)